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The habit of betel quid chewing is considered to be one of predominant risk factors for the induction of 
oral cancer, one of the leading malignancies in South Asian countries. Betel quid often consists of a 
mixture of betel leaf, areca nut, and slaked lime, with or without tobacco. Each component in betel quid 
may individually, synergistically, and coordinately participate in carcinogenesis. However, the underlying 
molecular mechanisms for the development of oral cancer remain unclear. Other environmental risk 
factors, such as tobacco smoking and alcohol consumption, often leading to oral cancer by inducing 
genetic and epigenetic modification. In addition to genetic modifications, DNA hypermethylation is one 
of most common epigenetic events observed in oral cancer. In fact, DNA hypermethylation of several 
tumor suppressor genes has been detected in precancerous lesions and oral cancers. Precancerous lesions 
with DNA hypermethylation followed by transcriptional downregulation of the tumor suppressor genes 
have a high risk of malignant transformation. However, few publications have identified DNA 
hypermethylation in betel quid-related oral cancer and precancerous lesions. Areca nut is one of the basic 
components in betel quid and contains several active chemical ingredients. One of major chemicals is 
arecoline and is considered to be the most significant procarcinogen present in betel quid. Previous studies 
have demonstrated that arecoline had a comprehensive effect on cellular gene expression and promote oral 
cancer. Arecoline may promote oral cancer by inducing transcriptional downregulation of the tumor 
suppressor genes and, that this downregulation is possibly induced by DNA hypermethylation. It is, 
however, the role of arecoline in DNA hypermethylation followed by downregulated transcriptional levels 
has not been clarified.  
Sirtuins (SIRTs) are class III histone deacetylase family protein, comprising seven members, SIRT1-7. 
SIRT1 was the first family member to be discovered and is the most studied molecule. SIRT1 is 
predominantly located in the nucleus, also in the cytosol and, targets both histone and non-histone cellular 
substrates. Dysregulation of SIRT1 expression has previously described in many human malignancies 
including oral cancer. However, the physiological relevance of SIRT1 in betel quid-related oral cancer 
remains unexplored. Betel quid-related oral cancer is often preceded by the development of precancerous 
lesions, characterized by the disruption of epithelial integrity and, consequently, the transformation to 
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invasive cancer. SIRT1 has been identified as playing a role in the maintenance of epithelial integrity and 
contributing to the prevention of both the invasion and metastasis potential of the oral epithelium. From 
these observations, we hypothesize that decreased SIRT1 expression may occur in oral cancer induced by 
betel quid chewing habit. Since the downregulated expression of SIRT1 has been attributed to DNA 
hypermethylation, we hypothesize that DNA hypermethylation of SIRT1 may be observed followed by its 
transcriptional downregulated expression in betel quid chewing oral cancer patients. 
In the present study, we analyzed whether the hypermethylation of SIRT1 followed by its transcriptional 
downregulation in the human gingival epithelial cells could be caused by arecoline, a major component of 
betel quid. In addition, we investigated the methylation status of SIRT1 in smear samples of 
macroscopically healthy buccal mucosa from subjects with a habit of betel quid chewing. Furthermore, we 
examined the methylation status of SIRT1 in paraffin-embedded tissue samples of oral squamous cell 
carcinoma (OSCC) obtained from betel quid chewing and non-chewing patients and in tissues samples 
from healthy control subjects. Our in vitro model showed that, DNA hypermethylation is involved in 
SIRT1 transcriptional downregulation following chronic stimulation with arecoline. The habits of betel 
quid chewing and the duration of chewing years are positively correlated with DNA methylation 
frequency of the SIRT1 gene of oral epithelia. We also revealed that SIRT1 was significantly 
hypermethylated in tissue samples of OSCC from betel quid chewers and non-chewers than in oral 
mucosa from healthy control subjects. Results also showed that hypermethylation of SIRT1 was 
significantly higher in OSCC from betel quid chewing patients than in that from non-chewing patients. 
Collectively, these results suggest that SIRT1 is involved in the oral cancer caused by betel quid chewing, 
and that hypermethylation of SIRT1 in the oral mucosa of betel quid chewers could be a predictive marker 
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Oral cancer is the fifteenth most frequent and major cause of death from cancer around the world (Ferlay 
et al., 2015). The highest prevalence rate of oral cancer has been reported in South Asian countries, 
including India, Pakistan, Sri Lanka, and Bangladesh, where it is the third most common and fifth leading 
cause of cancer death, followed by breast, lung, stomach, and cervical cancer (Ferlay et al., 2015). The 
mean age of occurrence of this disease in different parts of the oral cavity ranges between 51 and 55 years 
or above (Lee et al., 2011). Globally, this condition is more predominant in males than in females; in 
South Asian countries, it is the most common malignancy and third major cause of deaths in males, 
followed by lung and stomach cancer (Ferlay et al., 2015; Lee et al., 2011). The etiologies of oral cancer 
include betel quid chewing, smoking, alcohol consumption, genetic predisposition, and viruses, including 
human papillomavirus (HPV) (IARC, 2004; Chiba, 2001). The site of occurrence of this disease depends 
on region-specific epidemiological risk factors. In South Asian countries, the cheek (buccal mucosa) and 
gingiva are the leading sites of involvement, whereas, in western societies, the tongue is most commonly 
affected (Chiba, 2001). The high prevalence of oral cancer at characteristic sites in South Asian population 
may be attributed to the habit of BQ chewing, which is one of the main etiological factors for the 
development of this cancer and has been a significant threat to public health in these areas (IARC, 2004; 
Chiba et al., 1998; Chiba, 2001). The term ‘quid’ is defined as “a substance, or mixture of substances, 
placed in the mouth or chewed and remaining in contact with the mucosa, usually containing one or both 
of the two basic ingredients, tobacco and/or areca nut, in a raw or any manufactured or processed form” 
(Zain et al., 1999). Thus, BQ may be considered as any quid comprising of betel leaf and a combination of 
areca nut and slaked lime, with or without tobacco. The principal components of BQ and the prevalence of 
BQ chewing habits are shown in Figure 1 (Islam et al., 2019a). It has been described that different 
components of BQ act on the oral epithelium and induces generic and epigenetic alterations. Subsequently, 
these alterations lead to the initiation and promotion of oral carcinogenesis in the oral mucosa (Chiba, 




Areca nut is one of the basic ingredients wrapped in a betel leaf along with the other components of the 
BQ. The chemical composition of areca nut varies, and may include carbohydrates, fats, proteins, fiber, 
polyphenols, tannins, alkaloids, and various trace elements as the major constituents (Cox et al., 2004; 
Warnakulasuriya, 2002). Alkaloids, polyphenols, and tannins may be responsible for the areca 
nut-associated effects on oral mucosa. The major areca nut alkaloids are arecoline, arecaidine, guvacaine, 
and guvacoline, wherein, arecoline is the most abundant alkaloid and considered to be the most important 
procarcinogen present in areca nut (Cox et al., 2004; Warnakulasuriya, 2002). Arecoline undergoes a 
nitrosation reaction and gives rise to a variety of BQ-specific nitrosamines (BSNAs) within the acidic 
environment of the oral cavity and stomach. The formation of these nitrosamines induces oxidative stress 
by interacting with DNA, proteins or other macromolecules, and contributes to carcinogenesis in the oral 
mucosa, including epithelium and submucosal connective tissues (Islam et al., 2019a). However, the 
mechanisms by which nitrosamines interact with DNA or other macromolecules and exert their 
carcinogenic activities remain unclear. Arecoline, the main alkaloid present in the areca nut, induces 
chromatin relaxation by inhibiting poly (ADP-ribose) polymerase (PARP), a family of proteins involved 
in DNA repair and maintenance of genomic stability (Saikia et al., 1999). The relaxation of the chromatin 
structure by arecoline allows for the interaction of nitrosamines with DNA resulting in the formation of 
adducts. The formation of these DNA adducts may induce genomic alterations and the epigenetic 
silencing of tumor suppressor genes (TSGs) (Saikia et al., 1999; Islam et al., 2019a). It is, however, the 
role of arecoline in DNA hypermethylation followed by downregulated transcriptional levels of TSGs has 
not been clarified.  
DNA methylation is one of the several epigenetic mechanisms that cells use to control gene expression 
(Abiko et al., 2014). DNA methylation is an enzymatically catalyzed covalent modification of DNA, 
occurring typically in the context of Cytosine-Guanine (CpG) islands. The epigenetic alteration most 
studied in the human cancer cell is DNA methylation. The number of genes with aberrant methylation in 
the cancer cell is still unknown, but it is estimated that approximately 5% (approximately 1,500–2,000) of 
the human genome can be aberrantly methylated in a cancer cell (Bird, 1986; Esteller, 2007, 2008). 
Typically, there is hypermethylation of TSGs and hypomethylation of oncogenes. The silencing of TSGs 
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through hypermethylation appears to be especially important in progression to cancer, whereas 
hypomethylation is linked to chromosomal instability and loss of imprinting (Baylin et al., 2016). Therefore, 
aberrant DNA methylation without the presence of genetic alterations is now widely recognized as either a 
causative or correlative event in carcinogenesis (Esteller, 2007, 2008). Environmental risk factors, for 
instance, tobacco smoking, alcohol drinking, and BQ chewing often promote oral cancer by inducing 
genetic and epigenetic alterations (IARC, 2004; Petti et al., 2008). Both genetic and epigenetic factors 
often work together in affecting multiple cellular pathways in cell-cycle regulation, DNA repair, apoptosis, 
cell-to-cell adhesion and carcinogen metabolism which leads to tumor progression (Bailoor et al., 2015). 
In fact, it is well-documented that precancerous oral lesions with DNA hypermethylation followed by the 
transcriptional downregulation of TSGs have a high risk of malignant transformation (Shridhar et al., 
2016; Takuma et al., 2010). Hence, hypermethylation on oral epithelium can be one of the valuable 
markers for prediction of malignant potential of the lesions. 
The sirtuins (SIRTs) family protein are class III histone deacetylases (HDACs), comprised of seven 
members, SIRT1-7. SIRTs are widely expressed in normal tissues and involved in several biological 
processes (Carafa et al., 2016; Sebastian et al., 2012; Islam et al., 2019b). SIRT1 was the first family 
member to be discovered and is the most studied molecule. The functional activity of SIRT1 is dependent 
on availability of nicotinamide adenine dinucleotide (NAD+). High levels of NAD+ induce SIRT1 activity, 
whereas high NADH levels inhibit its function (Wang et al., 2008). SIRT1 is predominantly located in the 
nucleus and, also in the cytosol (Carafa et al., 2016). Due to SIRT1 localization, it is capable of 
deacetylating lysine residues on both histone and non-histone proteins, which is thought to affect their 
stability, transcriptional activity, and translocation (Wang et al., 2008). Deacetylation of histones by 
SIRT1 has been shown to induce chromatin condensation, whereas acetylation by histone 
acetyltransferases (HATs) causes chromatin decondensation (Wang et al., 2008). This balance is crucial 
for normal cellular functions, and any disturbance of it will be related to cancer (Gray et al., 2001). 
SIRT1-mediated deacetylation of non-histone proteins has been suggested to be more important in cancer 
than histones (Carafa et al., 2016; Sebastian et al., 2012). However, in tumor biology, SIRT1 seems to 
play contradictory roles and dysregulation of SIRT1 expression has frequently been reported in many 
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human malignant diseases including oral cancer (Islam et al., 2019b). Although, it remains controversial 
whether SIRT1 acts as a tumor suppressor or promoter in oral cancer and, preclinical data are inconclusive 
to address such debate.  
BQ-related oral cancer is often preceded by the development of precancerous lesions, characterized by 
disruption of epithelial integrity and consequently, transforming to invasive cancer. Interestingly, it was 
reported that stable expression of SIRT1 aids in maintaining epithelial integrity, and this contributes to the 
prevention of both invasion and metastasis. However, the involvement of SIRT1 in BQ-related oral cancer 
has not been clarified. These observations suggest that decreased SIRT1 expression may occur in oral 
cancer induced by BQ chewing habit. Since the downregulated expression of SIRT1 has been attributed to 
DNA hypermethylation, we hypothesize that DNA hypermethylation of SIRT1 may be observed followed 
by its transcriptional downregulated expression in BQ chewing oral cancer patients.  
In the present study, in order to characterize the association between chronic arecoline stimulation and 
carcinogenesis, we investigated whether the hypermethylation of SIRT1 followed by its transcriptional 
downregulation in the human gingival epithelial cells could be caused by arecoline. In addition, we 
examined the methylation status of SIRT1 in smear samples of macroscopically healthy buccal mucosa 
from subjects with a habit of BQ chewing. Furthermore, we analyzed the methylation status of SIRT1 in 
paraffin-embedded tissue samples of oral squamous cell carcinoma (OSCC) obtained from BQ chewing 
and non-chewing patients and in tissues samples from healthy control subjects for clarifying the role of 







2. MATERIALS AND METHODS 
1. Ethics statement 
All participants in the study provided written informed consent, and the study was approved by the 
Institutional Review Boards of the Ethics Committee on Human Genetic Research at the Health Sciences 
University of Hokkaido, Japan (Number# 2016-025) and the Ethical Committee at the University of 
Peradeniya, Sri Lanka (Number # 7/2004). 
2. Cell culture and arecoline exposure 
Human gingival epithelial progenitors (HGEPs) cells, primary keratinocytes derived from healthy gingival 
epithelium, were purchased from CELLnTEC Advanced Cell Systems (Basel, Switzerland) and cultured 
in CnT-Prime epithelial culture medium (CELLnTEC Advanced Cell Systems) at 37 °C in a humidified 
atmosphere of 95% air and 5% CO2. HGEPs cells were spread onto 100 mm tissue culture plates at a 
density of 4.0×104 cells/mL. Arecoline (arecoline hydrobromide) was purchased from Sigma-Aldrich (St. 
Louis, MO). Following overnight incubation, the HGEPs cells were treated with arecoline at a 
concentration of 50 μg/mL. The concentration of arecoline used in this study was as described in previous 
experiments (Uehara et al., 2017). Briefly, arecoline at the concentration of 50 µg/mL had no cytotoxic 
effect on the cells stimulated, even for a prolonged period, the method of alternating between 3 days with 
50 µg/mL of arecoline and 3 days without arecoline for 1 month was selected. The untreated samples 
were used as controls. The flow chart of cell-cultured is briefly shown in Figure 2. 
1): Quantitative methylation-specific polymerase chain reaction 
Genomic DNA was extracted from the HGEPs cells using DNeasy® Blood & Tissue Kit (Qiagen), 
following the manufacturer's instructions. The extracted DNA samples were treated with sodium bisulfite 
using the EpiTect® Plus Bisulfite Kits (Qiagen). DNA methylation of the SIRT1 gene was analyzed using 
SYBR green-based quantitative methylation-specific polymerase chain reaction (qMS-PCR) after 
checking the existence of CpG islands around the promoter region by UCSC Genome Browser 
(http://genome.ucsc.edu/index.html) (Fig. 3). Two sets of primers were used; one for methylated and one 
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for unmethylated DNA sequences (Oliveira et al., 2014). The primers used for SIRT1 gene were shown in 
Table 1. For PCR, the bisulfite-treated DNA template was mixed with KAPA SYBR FAST qPCR Kit and 
a pair of primers. The PCR conditions included initial incubation at 50 °C for 2 min, denaturing at 95 °C 
for 10 min, and 50 cycles of denaturing at 95 °C for 15 s and annealing at 58 °C for 1 min. After PCR 
amplification, a dissociation curve was generated to confirm the size of the PCR product. The percentage 
of DNA methylation in a sample was estimated using the following formula: 
Methylated DNA (%) =  x 100 =  x 100 =  x 100, 
where M is the copy number of methylated DNA, U is the copy number of unmethylated DNA, and ∆Ct = 
CtU - CtM (Katsaros et al., 2007). Each experiment was performed in triplicate. Data are expressed as mean 
± standard deviation (SD). 
2): Real-time quantitative reverse-transcription polymerase chain reaction  
Total RNA was extracted from the HGEPs cells using the RNeasy® Mini Kit (Qiagen) following the 
manufacturer's instructions. Total RNA was reverse transcribed into cDNA using a ReverTra Ace® qPCR 
RT Master Mix (Toyobo, Osaka, Japan). The cDNA levels were measured using the LightCycler® Nano 
System (Roche Diagnostics, Basel, Switzerland). The primers used for SIRT1 gene expression analysis 
were shown in Table 2 (Li et al., 2016; Murray et al., 2013). For real-time quantitative reverse 
transcription-polymerase chain reaction (qRT-PCR), cDNA was mixed with KAPA SYBR FAST qPCR 
Kit (Nippon Genetics, Tokyo, Japan) and a pair of primers. The PCR conditions included initial 
incubation at 50 °C for 2 min, denaturing at 95 °C for 10 min, 40 cycles of denaturing at 95 °C for 15 s 
and annealing at 60 °C for 1 min. The relative expression of each mRNA was calculated as the Ct (the 
value obtained by subtracting the Ct value of the GAPDH mRNA from the Ct value of the target mRNA) 
using the ∆∆Cq method (Livak et al., 2001). Specifically, the amount of target mRNA relative to GAPDH 
mRNA is expressed as 2-(∆Ct). Each experiment was performed in triplicate. Data are expressed as mean ± 
standard error (SE) of the ratio of the target mRNA to GAPDH mRNA.  
3): Western blotting analysis 
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Proteins were extracted from the HGEPs cells using lysis buffer [50 mM Tris HCL, pH 7.5; 10 mM 
EDTA, pH 7.5; 165 mM NaCl; 10 mM NaF; 1 % Nonidet P-40; 1 mM PMSF; 1 mM NaVO3; 10 μg/mL 
leupeptin; and 10 μg/mL aprotinin]. The lysis reaction was carried out for 1 h at 4°C. The samples were 
centrifuged at 15,000 rpm for 30 minutes at 4°C, and the supernatant was used as sample. Protein 
concentration quantified by Lowry’s protein assay. Fifteen micrograms of protein samples were used for 
western blotting analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out in pre-cast gels (4-20% gradient of polyacrylamide; Mini-PROTEAN TGX Gels; Bio-Rad, 
Hercules, CA, USA). After electrophoresis, gels were transferred electrophoretically onto polyvinylidene 
difluoride membranes (Immobilon-P; Millipore, Bedford, MA, USA) and blocked for 1 h with 
Tris-buffered saline (TBS) containing 5% skimmed milk. Blocked membranes were washed twice with 
TBS containing 0.05% Tween-20 solution.  
The primary antibodies used were: mouse monoclonal antibody against SIRT1 (dilution 1:1000, 
#ab110304; Abcam, Cambridge, MA, USA) and rabbit monoclonal antibody against GAPDH (dilution 
1:5000, #CST5174; Cell Signaling Technology, Danvers, Massachusetts, USA). Membranes were 
incubated with the primary antibody overnight at 4°C, washed three times with TBS containing 0.05% 
Tween-20 solution, and incubated with a horseradish peroxidase-conjugated secondary antibody (dilution 
1:10,000; Jackson Immuno-Research Laboratories Inc, West Grove, PA, USA) for 1 h at room 
temperature. Bands of SIRT1 and GAPDH were visualized by the enhanced chemiluminescence system 
(Clarity Max™ Western ECL Substrate; Bio-Rad) and LuminoGraph I (ATTO Corporation, Tokyo, 
Japan), and recorded using ImageSaver6 software (ATTO Corporation). Expression levels of SIRT1 and 
GAPDH in cells treated with or without arecoline were quantified by analyzing the intensity of each band 
using CS Analyzer4 software (ATTO Corporation). Each experiment was performed in triplicate. Data are 
expressed as mean ± SE of the ratio of the target protein to GAPDH protein.  
3. Buccal smear samples and clinicopathological data collection 
Prior to sample collection, the nature of the study was fully explained to all participants. Information 
obtained from the interview included socioeconomic and demographic characteristics, personal and family 
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histories, risk factors for oral cancer, such as lifestyle, alcohol drinking, tobacco smoking, and BQ 
chewing including its frequency, and the added use of betel leaf, areca nut, slaked lime, and tobacco. 
Clinic attendees of at least 20 years of age and with the ability to complete the questionnaires by an 
interview and clinical oral examinations were eligible to participate. The presence of oral mucosal lesions 
was evaluated and documented by a registered dentist, based on the recommendations of the World Health 
Organization (Kramer et al., 1978). Participants having oral mucosal lesions or any systemic disorders 
(such as diabetes, immune-compromised, or genetic diseases) were excluded from this study. A 
convenience sample of 70 study subjects was recruited and classified into two groups: controls (45 healthy, 
non-chewers) and BQ chewers (25 healthy, chewers). Both the controls and BQ chewer groups were 
non-smokers and non-drinkers. Subjects who had chewed one BQ per day for at least 6 months were 
considered as chewers. The brief description of the study subject, study design, and sample collection 
were shown in Figure 4. 
For oral cancer screenings, samples for biomarker testing should be easily available. Thus, the present 
study used samples obtained by buccal smear, which is noninvasive and easy to perform and which may 
assist in screening for oral cancers, particularly in areas with limited resources. Buccal smear samples 
were collected by research staff accordingly manufacturer instructions (Qiagen). Briefly, the participants 
were restricted in eating and drinking for 30 minutes prior to collection, and it was verified that the 
participant's mouth was empty. The swab sticks were removed from the package carefully to avoid 
contaminating the tip of the swab with gloves or against any surface. The swab was firmly rubbed and 
rotated the swab along the inside of the cheek for 5-10 times and, to ensure that the entire tip was in 
contact with the cheek, this step was repeated on the other cheek. The swab stick was removed from the 
mouth, being careful not to touch swab tips with any other surface such as teeth, lips, or other surfaces. 
The swab was placed directly into the tube containing the DNA stabilizing reagent Gentra® Puregene® 
buccal cell kits (Qiagen), and the tube was labeled with identifying information. Samples were stored at 
minus 20 degrees Celsius until shipment on ice to HSUH for testing. 
1): Quantitative methylation-specific polymerase chain reaction 
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Genomic DNA was extracted from the buccal smear samples using Gentra® Puregene® buccal cell kits 
(Qiagen), following the manufacturer's instructions. The extracted DNA samples were treated with 
sodium bisulfite using the EpiTect® Plus Bisulfite Kits (Qiagen) and DNA methylation of the SIRT1 gene 
was performed using the methods described previously (Katsaros et al., 2007). Each experiment was 
performed in triplicate. Data are expressed as mean ± SD of the DNA methylation.  
4. Tumor specimen and tissue collection  
Oral squamous cell carcinoma (OSCC) and normal oral mucosa tissue samples were obtained from 
patients treated surgically. Twelve OSCC tissue samples were obtained from patients with BQ chewing 
habit in Sri Lanka. Twenty-two OSCC tissue samples were obtained from Japanese patients without BQ 
chewing habits, and 13 normal oral mucosae were obtained from individuals who underwent oral surgical 
intervention from 2008 to 2014 at the Health Sciences University of Hokkaido (HSUH) Hospital. The 
postsurgical tissue sections were formalin-fixed, processed, and paraffin-embedded following standard 
protocols. None of these patients received chemotherapy or radiotherapy prior to tumor resection. Data on 
patient demographics were retrieved from the archives of the Oral Medicine and Pathology Department at 
HSUH, Japan. The study design and sample collection are briefly shown in Figure 5.  
1): Quantitative methylation-specific polymerase chain reaction 
Genomic DNA was extracted from the tissue samples using DNeasy® Blood & Tissue Kit (Qiagen, Venlo, 
Netherlands), following the manufacturer's instructions. The extracted DNA samples were treated with 
sodium bisulfite using the EpiTect® Plus Bisulfite Kits (Qiagen) and DNA methylation of the SIRT1 gene 
was performed using the method described previously (Katsaros et al., 2007). Each experiment was 
performed in triplicate. Data are expressed as mean ± SE of the DNA methylation. 
5. Statistical analysis 
Statistical analysis was performed on a database using IBM SPSS Statistics 23 (IBM, Armonk, NY). 
Comparisons between two groups were performed using the Mann-Whitney U test. Multiple variable 
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comparisons were performed by using multivariable regression analysis. Results with p-values of <0.05 





1: The effects of arecoline on SIRT1 DNA methylation, mRNA expression, and protein production 
In order to confirm whether the hypermethylation of SIRT1 caused by BQ chewing downregulates the 
transcriptional level of SIRT1 in HGEPs cells, HGEPs cells were stimulated with arecoline, a major 
component of BQ. The methylation level of SIRT1 in cells treated with arecoline at a concentration of 
50 μg/mL was significantly increased compared to that of control cells (Fig. 6a). The expression levels of 
SIRT1 mRNA in the cells treated with arecoline were significantly decreased compared to the control 
group (Fig. 6b). To determine whether the mRNA expression levels of SIRT1 relates to its protein 
production, further analysis was performed using western blotting to investigate the effects of arecoline on 
SIRT1 protein production. The protein levels of SIRT1 (bands of 120 kDa) was reduced by arecoline 
treatment in HGEPs cells compared to that in controls. On the other hand, the protein levels of GAPDH 
(bands of 37 kDa) was the same in all cells (Fig. 7a). The ratio of intensities of SIRT1 to GAPDH 
(SIRT1/GAPDH) in controls was considered to be 100%. The ratio of intensities of SIRT1/GAPDH in 
control and arecoline HGEPs cells were 100±16.2% and 40.1±3.3%, respectively. SIRT1 protein levels 
were reduced by arecoline in HGEPs cells (Fig. 7b). These results indicate that SIRT1 mRNA 
transcription is suppressed by arecoline, resulting in decreased protein production in HGEPs. Together, 
these results demonstrate that DNA hypermethylation is involved in SIRT1 transcriptional downregulation 
in HGEPs cells following chronic stimulation with arecoline. 
2: Subject characteristics and profiling of SIRT1 DNA methylation  
A total of 70 adult participants were enrolled in the current study, including 14 males and 56 females. 
Based on the history of oral habits, the participants were classified into two groups: controls (45; healthy, 
BQ non-chewers) and BQ chewers (25; healthy, chewers). The mean age of controls and BQ chewers 
were 35.5±13.6 years and 39.0±11.3 years, respectively. The mean chewing years in the BQ chewers 
group was 7.3±10.3 years. Of the 25 BQ chewers, 5 (24%) has used BQ for 6 months or more, 14 (56%) 
chewed for 1-10 years, and 5 (20%) has used BQ for more than 10 years. The mean DNA methylation 
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level of SIRT1 in controls and BQ chewers were 4.0 ± 4.6 and 16.5 ± 23.7, respectively. Detailed 
demographics of controls and BQ chewer groups are summarized in Table 3.  
3: The effects of betel quid chewing on SIRT1 DNA methylation status 
In this study, we investigated possible correlations between BQ chewing habits and the DNA methylation 
status of the SIRT1 promoter region in oral mucosal epithelium. Multivariable regression analysis was 
conducted using DNA methylation as a dependent variable, and age, sex, and BQ chewing habit as 
independent variables. The results showed that BQ chewing habit was the only significant predictor of 
SIRT1 DNA methylation level (Table 4; Fig. 8 A). This result suggests that DNA hypermethylation of 
SIRT1 is observed in macroscopically healthy BQ chewers epithelium before their clinical changes.  
4: The effects of betel quid components on SIRT1 DNA methylation status 
A total of 25 participants were enrolled in the BQ chewers group, including 5 (20%) males and 20 (80%) 
females. Of the 25 BQ chewers, 7 (18%) have used BQ in the combination of betel leaf and areca nut, and 
18 (72%) chewed BQ containing betel leaf, areca nut, and slaked lime. Based on the history of BQ 
components, the participants were classified into two groups: group 1 (7; betel leaf and areca nut) and 
group 2 (18; betel leaf, areca nut, and slaked lime). The detail demographics description was shown in 
Table 5.  
We investigated the possible correlation of BQ components and the DNA methylation level of SIRT1 in 
smear samples of BQ chewers. Multivariable regression analysis was conducted using DNA methylation 
as a dependent variable, and groups (group 1 and group 2) as independent variables. The results showed 
that no significant differences in SIRT1 DNA methylation levels were observed among groups and the 
frequency of quid chewing habits (Table 6). Together, these data suggest that DNA hypermethylation of 
SIRT1 could be caused by synergistic effects of BQ components onto the oral epithelium. 
5: The effects of chewing years on SIRT1 DNA methylation status 
Further, among the BQ chewers, we investigated the possible correlation of SIRT1 DNA methylation level 
and chewing years. The mean chewing years were 7.3±10.3 years. Multivariable regression analysis was 
13 
 
conducted using DNA methylation as a dependent variable, and age, sex, and chewing years as 
independent variables. It was revealed that the duration of chewing habit was only significantly correlated 
to the levels of SIRT1 DNA methylation (Table 7; Fig. 8 B). These results demonstrate that BQ chewing 
and the duration of BQ chewing habits are positively correlated with DNA methylation frequency of the 
SIRT1 gene of oral epithelia (Fig. 8 A-B). 
6: DNA methylation status of SIRT1 in oral squamous cell carcinoma (OSCC) obtained from BQ 
chewing and non-chewing patients 
We examined the promoter methylation status of SIRT1 in OSCC tissue samples obtained from BQ 
chewing and non-chewing patients, and oral mucosa samples from healthy control subjects. The 
demographic data of the participants are listed in Table 8. Multivariable regression analysis was 
conducted using DNA methylation as a dependent variable, and age, sex, groups (analysis I, BQ chewers 
vs healthy controls; analysis II, BQ non-chewers vs healthy controls; analysis III, BQ chewers vs BQ 
non-chewers) as independent variables. Analysis I investigates BQ chewing associated with OSCC, while 
analysis II investigates BQ non-chewing with OSCC. Analysis III investigates BQ chewing and 
non-chewing associated with OSCC. Analysis I revealed that SIRT1 was significantly hypermethylated in 
tissue samples of OSCC from BQ chewers than in oral mucosa from healthy control subjects (Table 9; Fig. 
9 A). Analysis II showed that SIRT1 was also significantly hypermethylated in tissue samples of OSCC 
from BQ non-chewers than in oral mucosa from healthy control subjects (Table 10; Fig. 9 B). Analysis III 
explored that SIRT1 was significantly hypermethylated in tissue samples of OSCC from BQ chewers than 
in that of OSCC of BQ non-chewers (Table 11; Fig. 9 C). Collectively, these results showed that SIRT1 
was significantly hypermethylated in tissue samples of OSCC from BQ chewers and BQ non-chewers 
than in oral mucosa from healthy control subjects. Results also showed that hypermethylation of SIRT1 
was significantly higher in OSCC from BQ chewing patients than in that from BQ non-chewing patients 






In the present study, our in vitro model showed that the hypermethylation is followed by downregulation 
of the transcriptional level of SIRT1. A higher level of methylation of SIRT1 was observed in smear 
samples obtained from macroscopically healthy buccal mucosa in BQ chewers than in non-chewers. 
Results also demonstrated DNA hypermethylation of SIRT1 in OSCC, and the methylation levels were 
significantly higher in the OSCC of BQ chewers than in that of non-chewers. These results suggest that 
SIRT1 is involved in the oral cancer caused by BQ chewing, and that hypermethylation of SIRT1 in the 
oral mucosa of BQ chewers could be a predictive marker for detecting early events of multistage 
carcinogenesis.  
Although hypermethylation of SIRT1 has been reported in several cancer tissues (Frazzi et al., 2016, 2017; 
Lisbosa et al., 2011), the hypermethylation of SIRT1 in OSCC has not been demonstrated. We confirmed 
the occurrence of SIRT1 hypermethylation in OSCC of BQ chewers and non-chewers. We also found that 
the hypermethylation level of SIRT1 was significantly higher in OSCC of patients with BQ chewing 
habits than in those of non-chewing habits. These results indicate that the DNA hypermethylation of 
SIRT1 caused by BQ chewing is involved in BQ-related OSCC. It was not known whether the 
hypermethylation of SIRT1 caused by BQ chewing is linked to SIRT1 transcription. The extraction of 
RNA from paraffin-embedded tissue samples remains extremely challenging, and no consensus or 
standardized isolation method has been described (Bohmann et al., 2009). Therefore, we employed an in 
vitro model of a daily BQ chewing habit that we showed previously to contain hypermethylated genes 
(Takai et al., 2016). The cells were stimulated with arecoline, a major component of BQ, for a prolonged 
period according to our previous protocol (Uehara et al., 2017). We confirmed that significantly high level 
of methylation of SIRT1 was observed followed by downregulated expression of SIRT1 transcription and 
protein expression. This hypermethylation of SIRT1 may cause the downregulated expression of SIRT1 
observed in OSCC. These results support previous findings suggesting SIRT1 as a tumor suppressor (Chen 
et al., 2014; Kang et al., 2018). SIRT1 has been reported to play a role in maintaining epithelial integrity 
by inducing the expression of epithelial-cadherin. Downregulation of SIRT1 expression may weaken 
epithelial-epithelial interaction leading to malignant transformation of the epithelia (Chen et al., 2014; 
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Kang et al., 2018). The hypermethylation of SIRT1 caused by arecoline in BQ chewers epithelium may be 
related to the instability of epithelial-epithelial interactions causing malignant transformation. It is still 
unknown how arecoline causes the hypermethylation of SIRT1. The promoter region of SIRT1 possesses a 
potential regulator of epigenetic factors, methyl-CpG-binding protein 2 (MeCP2) (Volkmann et al., 2013). 
MeCP2 has been shown to interact with DNA methyltransferase 1 (DNMT1) and recruits the latter to 
induces SIRT1 promoter methylation (Volkmann et al., 2013). Arecoline was previously documented to 
promote oral submucosal fibrosis and the progression to oral cancer through pathways involved in 
transforming growth factor-beta (TGF-β) production (Khan et al., 2012; Volkmann et al., 2013). TGF-β is 
likely to silence SIRT1 epigenetically by inducing the MeCP2 expression, although other possible 
mechanisms cannot be ruled out (Volkmann et al., 2013). TGF-β has shown to decrease miR-30a-3p 
expression, a negative regulator for MeCP2. Where overexpression of MeCP2 affects SIRT1 promoter 
methylation and subsequent epigenetic silencing (Volkmann et al., 2013). The formation of nitrosamines 
in BQ chewing epithelium supposed to be one of causative factor for DNA hypermethylation followed by 
epigenetic silencing (Saikia et al., 1999). Arecoline induces the formation of nitrosamines inside the oral 
mucosa of BQ chewers (Sundqvist et al., 1991). In fact, it is well-documented that the nitrosation of 
arecoline at neutral pH yielded approximately four times more areca nut specific nitrosamines than at 
acidic or alkaline pH (Nair et al., 2004). These nitrosamines could be related to downregulated 
transcriptional levels of SIRT1, as well as, other TSGs that were often observed in oral cancer of BQ 
chewing. Further studies are warranted to clarify this hypothesis. 
From these data, we hypothesized that the methylation level of SIRT1 in healthy oral epithelium of BQ 
chewing subjects is higher than that of non-chewing subjects. We showed that the methylation level of 
SIRT1 in smear samples obtained from macroscopically healthy buccal mucosa of BQ chewers is 
significantly higher than that in the samples of BQ non-chewers. In addition, the duration of chewing 
habits was correlated positively to the frequency of SIRT1 hypermethylation. This observation may 
support the previous paper that showed increasing the years of quid chewing habits were positively 
associated with oral cancer (Chen et al., 2017; Guha et al., 2014; Wang et al., 2017), wherein SIRT1 
hypermethylation may play an important role in the process of their development. The possible 
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involvement of SIRT1 in BQ-related oral cancer may explain by its inhibitory effects on TGF-β pathway 
(Chen et al., 2014). SIRT1 shows negatively regulate TGF-β pathway and its associated downstream 
molecules (Chen et al., 2014). These findings may explain the reasons why TGF-β and its associated 
downstream molecules are overexpressed in BQ-related oral cancer compared to BQ non-chewing oral 
cancers (Khan et al., 2012; Meng et al., 2011; Pant et al., 2016; Xiao et al., 2008). Wherein arecoline 
caused SIRT1 downregulation, and that this downregulated expression failed to prevent TGF-β-induced 
malignant transformation in oral epithelium of BQ chewers. Collectively, these findings indicate that 
DNA hypermethylation of SIRT1 caused by the habits BQ chewing is involved in malignant 
transformation potential of oral epithelium.   
Although, previously published reports confirmed DNA hypermethylation in precancerous lesions and 
oral cancer with the habits of BQ chewing (Chakraborty et al., 2017; González-Ramírez et al., 2011; 
Huang et al., 2013; Kaur et al., 2010; Shridhar et al., 2016; Takuma et al., 2010). It is, however, no 
studies have shown alteration of DNA methylation in the macroscopically healthy epithelium of BQ 
chewers. To be the best of our knowledge, this is the first report that showed DNA hypermethylation in 
clinical healthy oral epithelium of BQ chewers. This result indicates that DNA hypermethylation may be 
caused by some carcinogens as an early event of carcinogenesis before their clinical changes. Therefore, 
examination of SIRT1 hypermethylation, as well as, other TSGs in smears of buccal mucosa could be 
useful for the detection of early changes caused by BQ chewing habits.  
Samplings from buccal mucosa and saliva are the two most common non-invasive methods for genetic, 
epigenetic, and proteomic studies (Theda et al., 2018). However, salivary ribonucleases rapidly degrade 
epithelial cell RNA during collection, and usable RNA has not been extracted from scrapings of buccal 
mucosa (Ceder et al., 1985). Therefore, DNA methylation analysis using buccal smear samples may be 
used as a molecular screen for oral cancer, particularly in areas with limited resources. A few previous 
studies investigated interactions between BQ chewing habits and DNA methylation using smear samples 
from buccal OSCC (Huang et al., 2013; Yang et al., 2018). Those studies analyzed DNA methylation 
levels with participants having combined habits of BQ chewing, tobacco smoking, and alcohol drinking 
(Huang et al., 2013; Yang et al., 2018). Therefore, those studies might not reflect on the process of 
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carcinogenesis induced by habit of BQ chewing. Our study is the first report that shows increased levels of 
DNA methylation in healthy buccal mucosa samples obtained from BQ chewers. Cigarette smoking and 
alcohol consumption are other risk factors for oral cancer (Lee et al., 2013). Those habits also cause 
alteration of DNA methylation (Lee et al., 2013; Wang et al., 2017). In fact, previous studies demonstrate 
clear evidence that development of oral cancer follows the same biological pathways irrespective of the 
source of carcinogenic exposure (Dysvik et al., 2006; Lunde et al., 2010). The hypermethylation of SIRT1 
may be a target for the prediction of oral carcinogenesis caused by those habits, as well as BQ chewing. 






In conclusion, our data demonstrated for the first time that DNA hypermethylation of SIRT1 occurs in 
OSCC and normal oral mucosa obtained from BQ chewers and that the methylation status in buccal smear 
samples might be considered as an applicable routine oral screening procedure in high-risk populations, 
particularly in relation to BQ induced oral cancers. Further studies will, therefore, be necessary to confirm 
our findings, which might lead to a better understanding of the molecular basis of oral carcinogenesis 
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Table 1. Primer sequences used in sirtuin 1 (SIRT1) methylation levels analysis 
Gene Accession ID Primers (5' - 3') Product size (bp) Tm (°C) Reference 
SIRT1 
NM_012238 























Table 2. Primer sequences used in sirtuin 1 (SIRT1) gene expression levels analysis 
Gene Forward primer Reverse primer Reference 
SIRT1 GCGATTGGGTACCGAGATAA TTGCATGTGAGGCTCTATCC Murray et al., 2013 






















Table 3: Characteristics of human participants and buccal smear samples 
 Control (non-chewer) Betel quid chewer Total 
Samples, N (%) 45 (64.2) 25 (35.7) 70 (100) 
Male, N (%) 9 (20) 5 (20) 14 (20) 
Female, N (%) 36 (80) 20 (80) 56 (80) 
Age (mean ± SD) 35.5 ± 13.6 39.5 ± 12.0  
Duration of betel quid chewing habits 
≥ 6-months, N (%) 
1-10 years, N (%) 
> 10-years, N (%) 








7.3 ± 10.3 
25 (35.7) 
SIRT1 DNA methylation level (mean ± SD) 4.0 ± 4.6 16.5 ± 23.7 
 


















Table 4: Multivariable regression analysis of sirtuin 1 (SIRT1) DNA methylation level (total buccal smear samples) 
Variables B Standard error Beta t p-value 
Age .219 .134 .183 1.630 .108 
Sex (Male: 1, Female: 2) 3.107 4.314 .080 .720 .474 
Betel quid chewers vs non-chewers 11.633 3.645 .358 3.192 .002 
NOTE: Values in bold represent statistical significance (p<0.05). 























Table 5: Characteristics of betel quid components in smear samples of betel quid chewers 
 Group 1 Group 2 Total 
Samples, N (%) 7 (28) 18 (72) 25 (100) 
Male, N (%) 1 (4) 4 (16) 5 (20) 
Female, N (%) 6 (24) 14 (56) 20 (80) 
Total betel quid chewing (mean ± SD) 2673 ± 3414.8 5581.6 ± 7846.2  
SIRT1 DNA methylation level (mean ± SD) 7.0 ± 4.9 20.3 ± 27.0 
 
NOTE: Data are expressed as mean ± standard deviation (SD) 





















Table 6: Multivariable regression analysis of sirtuin 1 (SIRT1) DNA methylation level on betel quid components  
Variables 
B Standard error Beta t p-value 
Group 1 vs Group 2  10.618 10.342 .205 1.027 .316 
Quid number .001 .001 .354 1.771 .091 
Group 1, betel leaf and areca nut; Group 2, betel leaf, areca nut, and slaked lime  

























Table 7: Multivariable regression analysis of sirtuin 1 (SIRT1) DNA methylation level (betel quid chewer samples) 
Variables B Standard error Beta t p-value 
Age .189 .396 .095 .478 .638 
Sex (Male: 1, Female: 2) 9.529 9.782 .164 .974 .341 
Chewing years 1.280 .455 .558 2.814 .010 
NOTE: Values in bold represent statistical significance (p<0.05). 





























Table 8: Characteristics of patients and tissue samples  
 
BQ chewers OSCC  
 
BQ non-chewers OSCC Healthy controls 
Total  
Sri Lankan patients Japanese patients 
Samples, N (%) 12 (25.5) 22 (46.8) 13 (27.7) 47 (100) 
Male, N (%) 9 (75)   9 (40.9) 6 (46.2) 24 (51.1) 
Female, N (%) 3 (25)   13 (59.1) 7 (53.8) 23 (48.9) 
Age 56.3 ± 15.9        61.2 ± 15.2 58.5 ± 17.8  
SIRT1 DNA methylation level  41.4 ± 13.4          22.2 ± 14.3 11.2 ± 6.6  
NOTE: data are expressed as mean  standard deviation (SD).  











Table 9: Multivariable regression analysis of sirtuin 1 (SIRT1) DNA methylation level (BQ chewers OSCC vs healthy controls) 
Variables B Standard error Beta t p-value 
Analysis I      
Age .167 .138 .150 1.212 .239 
Sex (Male: 1, Female: 2) 6.228 4.783 .169 1.302 .207 
BQ chewers OSCC vs healthy controls 28.721 4.349 .793 6.604    .000 
NOTE: Values in bold represent statistical significance (p<0.05).  
BQ: betel quid; OSCC: oral squamous cell carcinoma  
 




















Table 10: Multivariable regression analysis of sirtuin 1 (SIRT1) DNA methylation level (BQ non-chewers OSCC vs healthy controls) 
Variables B Standard error Beta t p-value 
Analysis II      
Age .169 .124 .208 1.362 .183 
Sex 6.643 3.967 .255 1.675 .104 
BQ non-chewers OSCC vs healthy controls 11.837 4.076 .444 2.904  .007 
NOTE: Values in bold represent statistical significance (p<0.05). 
BQ: betel quid; OSCC: oral squamous cell carcinoma  























Table 11: Multivariable regression analysis of sirtuin 1 (SIRT1) DNA methylation level (BQ chewers OSCC vs BQ non-chewers OSCC) 
Variables B Standard error Beta t p-value 
Analysis III      
Age .055 .161 .051 .340 .736 
Sex 6.577 5.101 .201 1.289 .207 
BQ chewers OSCC vs BQ non-chewers OSCC 17.132 5.392 .501 3.177 .003 
NOTE: Values in bold represent statistical significance (p<0.05). 
BQ: betel quid; OSCC: oral squamous cell carcinoma  
 
































Figure 1. The major ingredients of betel quid and regions where betel quid chewing is prevalent 
(modification from Islam et al., 2019b). (A) the major ingredients of betel quid include the following: (a) 
betel leaf; (b) areca nut; (c) slaked lime, most commonly prepared in paste form; and (d) tobacco components 
(sun-dried or fermented). (b) The red areas on the map depict regions where betel quid chewing is prevalent 
in South Asia and the South Pacific Islands. The blue colored-areas represent the countries comprising 
habitual betel quid chewers originating from the Indian subcontinent; the countries include United Kingdom 
(mainly at Yorkshire, Birmingham, Leicester, East, and West London), South Africa (Durban and 
















Figure 2. Flow chart of cell culture. Human gingival epithelium progenitors (HGEPs), cells were treated 
with arecoline at a concentration of 50 μg/mL. The culture media was replaced every 3 days, alternating 
media with and without arecoline for 30 days. Untreated samples were used as controls. DDW, 





















Figure 3. Designing and identification of CpG island around the promoter region of the sirtuin 1 (SIRT1) 
gene. SIRT1 has three transcription variants. Transcription variants 1 (NM_O12238) has 9 exons. The 
CpG islands were located close to promoter areas at the transcription start sites of SIRT1. The product is 

















Figure 4. Buccal smear samples collection and distribution. (a) presence of oral mucosal lesions, systemic 
diseases, and habits of smoking and drinking subjects were eliminated followed by inclusion and 
exclusion criterions. (b) buccal smear samples of betel quid chewers and non-chewers were obtained from 

















Figure 5. Tissue samples collection and distribution. Paraffin-embedded tissues samples of oral squamous 
cell carcinoma (OSCC) grouped according to the habits of patients. The OSCC of BQ chewers tissue 
samples obtained from Sri Lankan patients and OSCC of non-chewers were from Japanese patients. The 
















Figure 6. (a) DNA methylation levels of sirtuin 1 (SIRT1) in human gingival epithelial progenitors 
(HGEPs) cells. The levels of SIRT1 DNA methylation in cells treated with 50 μg/mL arecoline were 
significantly increased compared to that in control cells. (b) SIRT1 mRNA expression levels in HGEPs 
cells. The expression levels of SIRT1 mRNA in cells treated with arecoline at 50 μg/mL was significantly 


















Figure 7. (a) sirtuin 1 (SIRT1) protein production in human gingival epithelial progenitors (HGEPs) cells. 
The production of SIRT1 protein (bands of 120 kDa) was reduced by arecoline treatment compared to 
controls. As a control, the levels of GAPDH (bands of 37 kDa) were similar in all cells. (b) The 
SIRT1/GAPDH protein expression ratio in HGEPs cells. The ratio of intensities of SIRT1 to GAPDH in 
control cells was considered to be 100%. The ratio of intensities of SIRT1/GAPDH in control cells and 
arecoline-treated cells was 100±16.2% and 40.1±3.3%, respectively. The SIRT1 protein levels were reduced 
by arecoline treatment. A value of p<0.05 was considered to be statistically significant (n=4). CTL, control; 



















Figure 8. (A) sirtuin 1 (SIRT1) DNA methylation levels in buccal smear samples of betel quid chewers and 
non-chewers. No significant correlation was observed in terms of age and gender to groups of betel quid 
chewers and non-chewers (a,b). Betel quid chewing habit was the only significant predictor of SIRT1 DNA 
methylation level (c). (B) SIRT1 DNA methylation levels in buccal smear samples of betel quid chewers. 
The chewing years of betel quid were significantly correlated to the levels of SIRT1 DNA methylation level 




Figure 9. (A) sirtuin 1 (SIRT1) DNA methylation levels in controls and oral squamous cell carcinoma 
(OSCC) of betel quid (BQ) chewers. SIRT1 was significantly hypermethylated in tissue samples of OSCC 
from BQ chewers than in oral mucosa from healthy control subjects. (B) SIRT1 DNA methylation levels in 
controls and OSCC of non-chewers. SIRT1 was significantly hypermethylated in tissue samples of OSCC 
from non-chewers than in oral mucosa from healthy control subjects. (C) SIRT1 DNA methylation levels in 
oral OSCC of non-chewers and OSCC of BQ chewers. SIRT1 was significantly hypermethylated in tissue 
samples of OSCC from BQ chewers than in that of OSCC of non-chewers. A value of p<0.05 was 
considered to be statistically significant. 
 
